MBX Biosciences, Inc.
Clinical-stage biopharma developing peptide therapies for endocrine diseases.
MBX | US
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 11711 N. MERIDIAN STREET, 46032 CARMEL
- Website:
- https://mbxbio.com/
- Sector:
- Manufacturing
Description
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for endocrine and metabolic diseases. The company is pioneering a proprietary platform of investigational Precision Endocrine Peptides (PEPs)™. This technology is designed to create highly specific and potent peptide therapeutics that address the underlying mechanisms of disease. MBX's pipeline targets rare and underserved endocrine disorders, such as hypoparathyroidism, with the goal of developing transformative, best-in-class medicines that simplify disease management and improve patients' quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all MBX Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MBX Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MBX Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
